uOmnispace.MR vs ElucidVivo A.3

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Shanghai United Imaging Healthcare Co., Ltd.
VS
by Elucid

AI Verdict

Tool A, uOmnispace.MR, provides comprehensive AI-powered analysis for various MR imaging applications, including general cardiac function and vessel analysis. In contrast, Tool B, ElucidVivo A.3, is a specialized AI system focused on quantitative analysis of arterial plaque composition and stability specifically from CT angiography. While both are AI-driven cardiovascular imaging tools, they cater to different diagnostic needs and utilize distinct imaging modalities.

Choose uOmnispace.MR if…

Choose uOmnispace.MR if your clinical practice requires a comprehensive, AI-powered solution for diverse magnetic resonance (MR) imaging analysis across multiple anatomical regions, including brain, breast, and cardiac studies. It is particularly well-suited for advanced post-processing needs such as MR Spectroscopy, perfusion analysis, and detailed cardiac function assessment.

View uOmnispace.MR →

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if your primary focus is on the precise, quantitative analysis of arterial plaque composition and stability from CT angiography for atherosclerosis patient stratification. This tool excels in providing detailed visualization and measurement of plaque characteristics, such as Lipid-Rich Necrotic Core, to optimize cardiovascular treatment decisions.

View ElucidVivo A.3 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature uOmnispace.MR ElucidVivo A.3
Pricing Contact for pricing Unknown
Deployment Software-only medical device; can run standalone or integrated with other cleared applications on standard off-the-shelf PCs; supports remote multi-user access on a network. The broader uOmnispace platform is available as SaaS, on-premise, or hybrid. Cloud and on-premise secure deployment.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

uOmnispace.MR

Tool A, uOmnispace.MR, offers flexible deployment options including standalone, integration with other applications, and remote multi-user access on a network, suggesting broader accessibility and ease of use in various clinical settings. Its broader uOmnispace platform also supports SaaS, on-premise, or hybrid models, indicating a versatile user experience. Tool B, ElucidVivo A.3, focuses on specific visualization features for plaque analysis, which while powerful, doesn't explicitly detail the same level of deployment flexibility or multi-user access.

Clinical Value

ElucidVivo A.3

While both tools are FDA-cleared and offer significant clinical utility, ElucidVivo A.3 stands out for its highly specialized and deeply validated quantitative analysis of arterial plaque composition and stability. Its ability to objectively quantify specific plaque components and derive fractional flow reserve (FFRct), validated against ground-truth histology, offers a unique and critical value in stratifying atherosclerosis patients and optimizing treatment decisions. uOmnispace.MR provides comprehensive MR analysis across diverse applications, but ElucidVivo A.3's specific, validated depth in a critical cardiovascular area gives it an edge in demonstrated clinical impact.

Pricing & Value

Tie

Both uOmnispace.MR and ElucidVivo A.3 require direct contact for pricing information. Without transparent pricing or publicly available data on return on investment (ROI) for either product, it is impossible to conduct a meaningful head-to-head comparison on this dimension.

Enterprise Readiness

uOmnispace.MR

uOmnispace.MR explicitly states HIPAA compliance, a Business Associate Agreement (BAA), and FDA clearance, along with diverse deployment options including SaaS, on-premise, and hybrid models, and support for remote multi-user access. ElucidVivo A.3, while FDA-cleared, only implies HIPAA compliance and BAA, and its deployment details are less explicit. Tool A's clear articulation of compliance and flexible deployment makes it appear more robustly prepared for enterprise integration.

Innovation

ElucidVivo A.3

Both tools leverage AI for advanced medical image analysis. However, ElucidVivo A.3 demonstrates a higher degree of specialized innovation through its unique capability to quantitatively analyze arterial plaque composition (e.g., Lipid-Rich Necrotic Core) and stability, validated against histology, and its derivation of FFRct. This specific, validated, and quantitative approach to a complex cardiovascular risk factor represents a significant advancement in non-invasive diagnostics. uOmnispace.MR offers a broad suite of AI-powered MR analysis tools, but ElucidVivo A.3's depth in a challenging and critical area is more innovative.

Support & Docs

Tie

Neither the provided structured facts nor general web searches yielded specific details regarding the level of customer support, available documentation, or training resources for either uOmnispace.MR or ElucidVivo A.3. Therefore, it is not possible to differentiate between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature uOmnispace.MR ElucidVivo A.3
Tool Name uOmnispace.MR ElucidVivo A.3
Company Shanghai United Imaging Healthcare Co., Ltd. Elucid Bioimaging
Description AI-powered software for comprehensive magnetic resonance (MR) image analysis, supporting diverse clinical applications including brain, breast, and cardiac imaging with advanced post-processing tools and AI-driven segmentation. FDA-cleared AI-powered medical image analysis system that provides quantitative analysis of arterial plaque composition and stability from CT angiography. It assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of plaque characteristics validated against histology.
Primary Imaging Modality MR (Magnetic Resonance) CT Angiography
Key Clinical Focus Comprehensive MR image analysis for brain, breast, and cardiac imaging, including AI-driven segmentation and advanced post-processing. Quantitative analysis of arterial plaque composition and stability from CT images for atherosclerosis patient stratification and treatment optimization.
Specialties Cardiology, Neurology, Radiology Cardiology, Radiology, Vascular Surgery

Videos

Demos, reviews, and walkthroughs featuring uOmnispace.MR and ElucidVivo A.3.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

uOmnispace.MR is designed for comprehensive magnetic resonance (MR) image analysis across various clinical applications. In contrast, ElucidVivo A.3 specializes in quantitative analysis of arterial plaque composition and stability exclusively from CT angiography images.
uOmnispace.MR supports diverse clinical applications including brain, breast, and cardiac imaging with advanced post-processing tools and AI-driven segmentation. ElucidVivo A.3 assists physicians in atherosclerosis patient stratification and optimizes treatment decisions by offering detailed visualization and measurement of plaque characteristics from CT images.
uOmnispace.MR features AI-driven cardiac ventricular segmentation and general AI-powered MR image analysis. ElucidVivo A.3 provides AI-powered quantitative analysis to objectively quantify Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, and derives fractional flow reserve (FFRct).
uOmnispace.MR is relevant for Cardiology, Neurology, and Radiology specialties. ElucidVivo A.3 is primarily suited for Cardiology, Radiology, and Vascular Surgery, focusing on cardiovascular care.
uOmnispace.MR uniquely offers MR Spectroscopy (SVS and CSI), perfusion analysis (e.g., Brain Perfusion), and stitching for full-format MR images. ElucidVivo A.3 uniquely provides quantitative analysis of arterial plaque composition validated against ground-truth histology and derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity.
AI Tool Finder
AI-powered search. Results may not be comprehensive.